{"id":411474,"date":"2021-01-09T13:18:30","date_gmt":"2021-01-09T18:18:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=411474"},"modified":"2021-01-09T13:18:30","modified_gmt":"2021-01-09T18:18:30","slug":"srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/","title":{"rendered":"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span>, Jan. 9, 2021<\/span> \/PRNewswire\/ —\u00a0Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public.<\/p>\n

\n

\n
\n \"Rosen
\n <\/a>\n <\/p>\n<\/p><\/div>\n

On January 7, 2021<\/span>, after market hours, Sarepta announced its gene therapy as a one-time treatment for the rare disorder Duchenne muscular dystrophy failed to show benefits compared with a placebo. Sarepta’s shares dropped almost 49.7%, or $83.95<\/span>, from closing at $168.95<\/span> on January 7, 2021<\/span> to open at $85.00<\/span> on January 8, 2021<\/span>.<\/p>\n

Rosen Law Firm is preparing a securities lawsuit on behalf of Sarepta shareholders. If you purchased securities of Sarepta please visit the firm’s website at http:\/\/www.rosenlegal.com\/cases-register-2018.html<\/a>\u00a0to join the securities action. You may also contact Phillip Kim<\/span> of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com<\/a>\u00a0or cases@rosenlegal.com<\/a>.<\/p>\n

Follow us for updates on LinkedIn: https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>\u00a0or on Twitter: https:\/\/twitter.com\/rosen_firm<\/a>\u00a0or on Facebook: https:\/\/www.facebook.com\/rosenlawfirm<\/a>.<\/p>\n

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. <\/p>\n

Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

——————————-<\/p>\n

Contact Information:<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0 Laurence Rosen, Esq.<\/span>
\u00a0\u00a0\u00a0\u00a0\u00a0 Phillip Kim, Esq.<\/span>
\u00a0\u00a0\u00a0\u00a0\u00a0 The Rosen Law Firm, P.A.
\u00a0\u00a0\u00a0\u00a0\u00a0 275 Madison Avenue, 40th<\/sup> Floor
\u00a0\u00a0\u00a0\u00a0\u00a0 New York, NY<\/span> 10016
\u00a0\u00a0\u00a0\u00a0\u00a0 Tel: (212) 686-1060
\u00a0\u00a0\u00a0\u00a0\u00a0 Toll Free: (866) 767-3653
\u00a0\u00a0\u00a0\u00a0\u00a0 Fax: (212) 202-3827
\u00a0\u00a0\u00a0\u00a0\u00a0 lrosen@rosenlegal.com<\/a>
\u00a0\u00a0\u00a0\u00a0\u00a0 pkim@rosenlegal.com<\/a>
\u00a0\u00a0\u00a0\u00a0\u00a0 cases@rosenlegal.com<\/a>
\u00a0\u00a0\u00a0\u00a0\u00a0 www.rosenlegal.com<\/a><\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-firm–srpt-301204689.html<\/a><\/p>\n

SOURCE Rosen Law Firm, P.A.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK, Jan. 9, 2021 \/PRNewswire\/ —\u00a0Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. On January 7, 2021, after market hours, Sarepta announced its gene therapy as a one-time treatment for the rare disorder Duchenne muscular dystrophy failed to show benefits compared with a placebo. Sarepta’s shares dropped almost 49.7%, or $83.95, from closing at $168.95 on January 7, 2021 to open at $85.00 on January 8, 2021. Rosen Law Firm is preparing a securities lawsuit on behalf of Sarepta shareholders. If you purchased … <\/p>\n

Continue reading “SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-411474","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPT - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPT - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Jan. 9, 2021 \/PRNewswire\/ —\u00a0Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. On January 7, 2021, after market hours, Sarepta announced its gene therapy as a one-time treatment for the rare disorder Duchenne muscular dystrophy failed to show benefits compared with a placebo. Sarepta’s shares dropped almost 49.7%, or $83.95, from closing at $168.95 on January 7, 2021 to open at $85.00 on January 8, 2021. Rosen Law Firm is preparing a securities lawsuit on behalf of Sarepta shareholders. If you purchased … Continue reading "SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-09T18:18:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT\",\"datePublished\":\"2021-01-09T18:18:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/\"},\"wordCount\":373,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/\",\"name\":\"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPT - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\",\"datePublished\":\"2021-01-09T18:18:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPT - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/","og_locale":"en_US","og_type":"article","og_title":"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPT - Market Newsdesk","og_description":"PR Newswire NEW YORK, Jan. 9, 2021 \/PRNewswire\/ —\u00a0Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. On January 7, 2021, after market hours, Sarepta announced its gene therapy as a one-time treatment for the rare disorder Duchenne muscular dystrophy failed to show benefits compared with a placebo. Sarepta’s shares dropped almost 49.7%, or $83.95, from closing at $168.95 on January 7, 2021 to open at $85.00 on January 8, 2021. Rosen Law Firm is preparing a securities lawsuit on behalf of Sarepta shareholders. If you purchased … Continue reading \"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-09T18:18:30+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT","datePublished":"2021-01-09T18:18:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/"},"wordCount":373,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/","name":"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPT - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","datePublished":"2021-01-09T18:18:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srpt-equity-alert-rosen-global-investor-counsel-announces-investigation-of-securities-claims-against-sarepta-therapeutics-inc-encourages-investors-with-losses-exceeding-1-million-to-contact-fir\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm – SRPT"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=411474"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411474\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=411474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=411474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=411474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}